SUMMARY Among 10 patients with endometriosis CA 125 was increased (> 35 U/ml) 
CA 125 is an antigen recognised by the monoclonal antibody OC 125 obtained through somatic hybridisation of splenic cells of mice immunised with a cell line of OVCA 433 ovarian cancer.' The antigen is expressed by most common epithelial ovarian carcinomas. In non-malignant tissue the antigen is frequently expressed in benign ovarian tumours ofmucinous and non-mucinous origin.25 as well as in endometriosis.'
The presence of the antigen has also been shown in human milk,'0 amniotic fluid," cervical mucus,'2 central airway and lung tissue'3 and seminal plasma. '4 These findings suggest that CA 125 may be a secretory product of many normal human epithelia. The The SDS-PAGE gels were subjected to electrophoretic transfer in TRIS-glycine buffer (25 mM and 192 mM, respectively), pH 8-3, containing 20% methanol, using the Transblot system (Biorad Laboratories, Richmond, California). Proteins and glycoproteins were transferred to nitrocellulose membrane filters (Schlecher and Schuell, GmbH, Dassel, West Germany), washed in PBS containing 0-4 M NaCl and 0-2% Tween 20 (PNT), and blocked in 1% bovine serum albumin in PNT for 30 minutes. After rinsing in distilled water the membrane was incubated in OC 125 at a I in 20 dilution in PNT for 30 minutes. After being washed three to four times in PNT buffer the membrane was incubated in '251-labelled antimouse IgG for 30 minutes. Excess radioactivity was washed off with 01% w/v SDS in PBS. After staining with amido black (Sebia) the membrane was dried and exposed to x-ray film (Fuji Photo Film Company, Japan) at -70°C for 24 hours.
The serum samples and endometriotic cysts fluid were analysed for CA 125 content by an immunoradiometric assay according to the manufacturer's instructions (CIS, UK). 
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